What is enzymatic methyl sequencing?

EM-seq
methylation
sequencing
methods
How EM-seq reads DNA methylation while preserving precious low-input cfDNA—and why that matters for this study
Author

Methylation & Colitis team

Published

August 24, 2026

Reading an extra layer of DNA

DNA sequence tells us which bases are present. DNA methylation adds another layer: chemical marks associated with gene regulation, cell identity, inflammation, aging, and disease. Enzymatic methyl sequencing—EM-seq—helps measure that layer at single-base resolution while avoiding much of the DNA damage caused by traditional bisulfite conversion (Vaisvila, Ponnaluri, Sun, and others, 2021).

Scientific illustration of nucleosomes, DNA fragments, enzymatic methyl sequencing, paired reads, and analytical profiles

EM-seq carries nucleosome-protected cfDNA through enzymatic conversion, paired-end sequencing, and joint methylation–fragmentomics analysis.

Molecular illustration of chromatin, nucleosome-protected cfDNA fragments, CpG methyl groups, and paired-end reads

At molecule level, paired-end reads preserve fragment geometry while enzymatic conversion reveals methylated CpG evidence.

Why methylation needs special chemistry

A sequencing instrument normally reads cytosine whether it carries a methyl group or not. The assay therefore needs a way to make modified and unmodified cytosines produce different sequencing results.

Traditional bisulfite sequencing uses harsh chemistry to convert unmodified cytosines. It is powerful, but the treatment can fragment and unevenly degrade DNA. That is especially problematic when the starting material is plasma cfDNA: scarce molecules that are already short.

EM-seq in motion

In simplified terms, EM-seq preserves modified cytosines and changes unmodified cytosines into a different sequencing signal. Software aligns the converted reads and counts methylated and unmethylated evidence at CpG sites.

NoteAn important detail

Standard EM-seq generally reports protected 5mC and 5hmC together. Without an additional assay, it should be described as modified-cytosine signal rather than a clean separation of those two marks.

Why this study needs it

This project compares methylation in plasma cfDNA and colonic tissue DNA. The two materials create different technical demands:

Study need How EM-seq helps What still needs checking
Very limited plasma cfDNA Supports low-input library preparation with less destructive conversion Yield, complexity, duplication, and minimum input
Single-base methylation Produces CpG-level evidence for DML and DMR analysis Conversion controls, coverage, and multiple testing
Paired tissue and plasma Uses a common assay family for within-participant comparison Different extraction, fragmentation, and cell mixtures
Plasma fragmentomics Paired reads may retain native molecule lengths and ends Library chemistry must preserve those physical features
Pathway interpretation DMRs can be mapped to genes and tested pathways Mapping rules and tested-region background must be explicit

The fragmentomics bonus

EM-seq reads contain more than methylation calls. If native plasma molecules remain intact during preparation, paired-end alignments can also describe:

  • fragment-length distributions and short-fragment ratios;
  • mono- and di-nucleosomal patterns;
  • fragment-end positions and sequence motifs;
  • coverage near transcription start sites; and
  • relationships between fragment length and methylation.

That link is biologically interesting because cfDNA fragmentation is shaped partly by nucleosome packaging, chromatin accessibility, and nuclease activity (Lo, Han, Jiang, and Chiu, 2021). Tissue DNA is deliberately sheared, so its laboratory-created insert lengths cannot serve as native tissue fragmentomics.

What EM-seq cannot do alone

EM-seq does not identify which cell released every plasma molecule, prove that a methylation difference changes gene expression, or establish that a patient is progressing toward cancer. Those questions need paired tissue context, cell-mixture modeling, other biological measurements, and—especially for progression—longitudinal validation.

flowchart LR
  E["EM-seq reads"] --> M["CpG methylation"]
  E --> F["Plasma fragment features"]
  M --> T["Tissue–plasma comparison"]
  F --> T
  S["sIgA + inflammation"] --> T
  T --> H["Candidate biological<br/>hypothesis"]
  H --> V["Independent longitudinal<br/>validation required"]

ImportantWhy it is valuable here

EM-seq protects the study’s most limited material, provides high-resolution methylation measurements, and may preserve a second physical signal from plasma fragments. That makes each carefully collected cfDNA molecule more informative—but only if assay QC and interpretation remain rigorous.

Follow the complete genomics pipeline → · See why tissue and plasma are paired →

Continue with the short fragmentomics explainer →

References

Romualdas Vaisvila, Vamsi K. C. Ponnaluri, Zhe Sun, and others. (2021). Enzymatic methyl sequencing detects DNA methylation at single-base resolution from picograms of DNA. Genome Research. https://doi.org/10.1101/gr.266551.120.
Y. M. Dennis Lo, Diana S. C. Han, Peiyong Jiang, and Rossa W. K. Chiu. (2021). Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies. Science. https://doi.org/10.1126/science.aaw3616.
Back to top